Peripheral vasodilators

Ratan K. Banik, Jay S. Berger

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Vasodilators, as their name imply, treat hypertension by causing the smooth muscle walls of blood vessels to relax, thus dilating the vessel. The systemic peripheral vascular resistance (afterload) is reduced by dilating on the arterial side of the vascular system. The peripheral venous return (preload) is reduced by dilating the veins. The overall effect is a decrease in arterial blood pressure, an increase in ventricular output, and a decrease in end-diastolic volume. In hypovolemic states, vasodilators must be used with caution because they can worsen perfusion to vital organs. Most vasodilating medications to some degree work on both the arterial side and the venous side of the vascular system. However, some vasodilators work more specifically on one side or the other. These medications are used in a wide variety of disease states, such as coronary artery disease, heart failure, and hypertension. The effectiveness of vasodilator treatment for patients with chronic congestive heart failure has been demonstrated in large multicenter clinical trials (Vasodilator-Heart Failure Trial I and II). The combination of different vasodilators has been shown to significantly improve symptoms, exercise tolerance, and survival of heart failure patients.

Original languageEnglish (US)
Title of host publicationEssentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care
PublisherSpringer New York
Pages257-273
Number of pages17
ISBN (Electronic)9781461489481
ISBN (Print)9781461489474
DOIs
StatePublished - Jan 1 2015

Fingerprint Dive into the research topics of 'Peripheral vasodilators'. Together they form a unique fingerprint.

Cite this